Clinical and Experimental Dermatology

Article	Citations
Treatment options for leishmaniasis	73
Anti‐interleukin‐23 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real‐world practice	60
COVID‐19 vaccine‐induced Stevens–Johnson syndrome	55
Skin manifestations of COVID‐19 in children: Part 1	53
Performance of ChatGPT on Specialty Certificate Examination in Dermatology multiple-choice questions	47
Line‐field optical coherence tomography: in vivo diagnosis of basal cell carcinoma subtypes compared with histopathology	44
Janus kinase inhibitors for atopic dermatitis: a promising treatment modality	43
COVID‐19 vaccination and patients with psoriasis under biologics: real‐life evidence on safety and effectiveness from Italian vaccinated healthcare workers	42
Abrupt onset of Sweet syndrome, pityriasis rubra pilaris, pityriasis lichenoides et varioliformis acuta and erythema multiforme: unravelling a possible common trigger, the COVID‐19 vaccine	41
Novel targets and therapies for keloid	40
Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA‐based or adenoviral vector‐based SARS‐CoV‐2 vaccination	39
Line‐field confocal optical coherence tomography for actinic keratosis and squamous cell carcinoma: a descriptive study	39
De novo generalized pustular psoriasis following Oxford‐AstraZeneca COVID‐19 vaccine	39
Skin manifestations of COVID‐19 in children: Part 2	37
Video and telephone teledermatology consultations during COVID-19 in comparison: patient satisfaction, doubts and concerns	36
Asymmetrical cutaneous vasculitis following COVID‐19 vaccination with unusual eosinophil preponderance	36
The impact of COVID-19 infection on patients with psoriasis treated with biologics: an Italian experience	35
Strategies adopted in a southern Italian referral centre to reduce adalimumab discontinuation: comment on ‘Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?’	35
Associations of particulate matter with atopic dermatitis and chronic inflammatory skin diseases in South Korea	33
Immune response to COVID-19 mRNA vaccination in patients with psoriasis undergoing treatment with biologics	33
Clinical characteristics and disease burden in prurigo nodularis	31
A flare of pre‐existing erythema multiforme following BNT162b2 (Pfizer–BioNTech) COVID‐19 vaccine	31
Vitiligo in a COVID‐19‐vaccinated patient with ulcerative colitis: coincidence?	29
Different types of emollient cream exhibit diverse physiological effects on the skin barrier in adults with atopic dermatitis	27
ChatGPT-3.5 and ChatGPT-4 dermatological knowledge level based on the Specialty Certificate Examination in Dermatology	27

Vitiligo: an update on systemic treatments	26
Merkel cell carcinoma	25
Skin manifestations of COVID‐19 in children: Part 3	25
Anifrolumab for treatment of refractory cutaneous lupus erythematosus	25
Tofacitinib for the treatment of refractory pyoderma gangrenosum	24
Pityriasis rubra pilaris‐like eruption following administration of the BNT163b2 (Pfizer–BioNTech) mRNA COVID‐19 vaccine	24
Vesiculobullous skin reactions induced by COVID‐19 mRNA vaccine: report of four cases and review of the literature	24
Comorbidities of alopecia areata: a population‐based cohort study	24
Dermatological effects of Curcuma species: a systematic review	24
Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32‐week real‐world experience during the COVID‐19 pandemic	23
Morphological evaluation of melanocytic lesions with three-dimensional line-field confocal optical coherence tomography: correlation with histopathology and reflectance confocal microscopy. A pilot st	23
TikTok™ and dermatology: promises and pearls	22
Mask‐induced dermatoses during the COVID‐19 pandemic: a questionnaire‐based study in 12 Korean hospitals	20
Management of patients with hidradenitis suppurativa during COVID-19 vaccination: an experience from southern Italy. Comment on: ‘Evaluating the safety and efficacy of COVID-19 vaccination in patients	20
Erythroderma (exfoliative dermatitis). Part 1: underlying causes, clinical presentation and pathogenesis	19
Radiation recall dermatitis triggered by inactivated COVID‐19 vaccine	18
Cutaneous thrombosis associated with skin necrosis following Oxford‐AstraZeneca COVID‐19 vaccination	17
A clinical review and history of pubic lice	17
Symmetrical drug‐related intertriginous and flexural exanthema like eruption associated with COVID‐19 vaccination	17
Clinical and demographic features of hidradenitis suppurativa: a multicentre study of 1221 patients with an analysis of risk factors associated with disease severity	17
TikTok™ and dermatology: lessons for medical education	17
Paternal and maternal use of dupilumab in patients with atopic dermatitis: a case series	16
COVID‐19 vaccines do not trigger psoriasis flares in patients with psoriasis treated with apremilast	16
Environmentally sustainable dermatology	16
Baricitinib for recalcitrant subacute cutaneous lupus erythematosus with concomitant frontal fibrosing alopecia	16
Linear IgA bullous dermatosis following Oxford AstraZeneca COVID‐19 vaccine	16
Primary cutaneous anaplastic large‐cell lymphoma: a review of the SEER database from 2005 to 2016	15
Perceptions of the use of artificial intelligence in the diagnosis of skin cancer: an outpatient survey	15
Quality of life and sexuality in women with lichen sclerosus: a cross‐sectional study	15
Hydroquinone: myths and reality	15
COVID‐19‐induced toxic epidermal necrolysis	15
Differential diagnosis and management of hyperpigmentation	14
Generalized bullous fixed drug eruption after Oxford–AstraZeneca (ChAdOx1 nCoV‐19) vaccination	14
#corticophobia: a review on online misinformation related to topical steroids	14
Eczematous drug eruption in patients with psoriasis under anti‐interleukin‐17A: does interleukin‐22 play a key role?	14
Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results	14
Ribonucleic acid COVID‐19 vaccine‐associated cutaneous adverse drug events: a case series of two patients	14
Porocarcinoma: a review	14
Treatment of pemphigoid gestationis with dupilumab	13
Risk of skin cancer after ultraviolet phototherapy in patients with vitiligo: a systematic review and meta-analysis	13
Evaluation of the Dermatological Life Quality Index, sexual dysfunction and other psychiatric diseases in patients diagnosed with vitiligo with and without genital involvement	13
Severe cutaneous adverse reaction following COVID‐19 vaccination and immunotherapy: a second hit?	13
Childhood rosacea and related disorders	13
Establishing the efficacy and safety of the novel use of common salt for the treatment of pyogenic granuloma	12
Interleukin-17A immune pattern across genetic acantholytic and blistering disorders	12
Cigarette smoking and risk of herpes zoster: a population‐based cohort study in Taiwan	12
Usefulness of high‐frequency ultrasonography in the evaluation and monitoring of sclerosing dermatoses: a cohort study	12
Efficacy of dupilumab for controlling severe atopic dermatitis with dominant‐negative CARD11 variant	12
Successful use of tofacitinib in epidermolysis bullosa pruriginosa	12
Ketoconazole 2% cream alters the skin fungal microbiome in seborrhoeic dermatitis: a cohort study	12

Allergic and cutaneous reactions following inactivated SARS‐CoV‐2 vaccine (CoronaVac ® ) in healthcare workers	12
Refractory Type I pityriasis rubra pilaris treated with tildrakizumab	12
Tralokinumab treatment for patients with moderate-to-severe atopic dermatitis in daily practice	12
Dermatological surgery: an update on suture materials and techniques. Part 1	12
Remote consultations for patients with hidradenitis suppurativa during the COVID‐19 pandemic: a single‐centre experience	12
Male genital lichen sclerosus associated with urological interventions and microincontinence: a case series of 21 patients	12
Clinical characteristics, quality of life and risk factors for severity in palmoplantar pustulosis: a cross‐sectional, multicentre study of 263 patients	12
Phenotypic switch from atopic dermatitis to psoriasis during treatment with upadacitinib	12
A Piez-o the jigsaw: the Piezo1 channel in skin biology	11
Pyridoxine for prevention of hand–foot syndrome caused by chemotherapy agents: a meta‐analysis	11
Analysis of the first 5 years of an interdisciplinary Rheumatology–Dermatology clinic	11
Unleashing carbon emissions savings with regular teledermatology clinics	11
Shaping the future of teledermatology: a literature review of patient and provider satisfaction with synchronous teledermatology during the COVID-19 pandemic	11
Severe atopic dermatitis treated successfully with dupilumab throughout pregnancy	11
Alopecia areata and risk of atopic and autoimmune conditions: population-based cohort study	11
Evidence for cutaneous dysbiosis in dystrophic epidermolysis bullosa	11
Structural and functional differences in skin of colour	11
Kawasaki disease for the paediatric dermatologist: skin manifestations and new insights into the pathophysiology	11
Dermoscopic features and screening strategies for the detection of small‐diameter melanomas	11
Dermoscopy of papulopustular rosacea and comparison of dermoscopic features in patients with or without concomitant Demodex folliculorum	10
Probiotics in hidradenitis suppurativa: a potential treatment option?	10
Successful treatment of trichothiodystrophy with dupilumab	10
Obesity and hidradenitis suppurativa: targeting meta-inflammation for therapeutic gain	10
Equal rates of drug resistance in leprosy cases with relapse and recurrent/chronic Type 2 reaction: time to revise the guidelines for drug‐resistance testing in leprosy?	10
Efficacy and safety of upadacitinib in adult patients affected by moderate to severe atopic dermatitis: a 16-week real-life dual-centre experience	10
An analysis of qualitative responses from a UK survey of the psychosocial wellbeing of people with skin conditions and their experiences of accessing psychological support	10
Tolerability profile of topical cannabidiol and palmitoylethanolamide: a compilation of single‐centre randomized evaluator‐blinded clinical and in vitro studies in norma	10
Long‐term antibiotic use for the treatment of hidradenitis suppurativa consistent with guideline recommendations	10
Psoriasis and osteoporosis: a literature review	10
Safety of tacrolimus 0.03% and 0.1% ointments in young children with atopic dermatitis: a 36‐month follow‐up study	10
Paradoxical eczema in patients with psoriasis receiving biologics: a case series	10
Ultraviolet radiation‐induced degradation of dermal extracellular matrix and protection by green tea catechins: a randomized controlled trial	10
A novel c.671_682del NCSTN variant in a family with hidradenitis suppurativa: a pilot study	9
Effects of systemic therapies on pruritus in adults with atopic dermatitis: a systematic review and meta-analysis	9
Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a patient with psoriasis. Comment on ‘Paradoxical hidradenitis suppurativa due to anti-int	9
Acute urticaria alone after CoronaVac COVID-19 vaccination should not be a contraindication for revaccination	9
Association between moderate to severe atopic dermatitis and lifestyle factors in the Dutch general population	9
A novice's guide to qualitative health professions education research	9
Cost-effectiveness of topical pharmacological, oral pharmacological, physical and combined treatments for acne vulgaris	9
Scratching the surface: a review of online misinformation and conspiracy theories in atopic dermatitis	9
Improvement of Hailey–Hailey disease with abrocitinib	9
Pyoderma gangrenosum caused by secukinumab successfully treated with risankizumab: a case report and literature review	9
Treatment of refractory subacute cuataneous lupus erythematosus with baricitinib	9
Assessment of inter‐rater reliability of clinical hidradenitis suppurativa outcome measures using ultrasonography	9
Comment on ‘ De novo generalized pustular psoriasis following Oxford‐AstraZeneca COVID‐19 vaccine’: possible role for Type I interferons	9
Comparison of the clinical efficacy of subcutaneous vs. oral administration of methotrexate in patients with psoriasis vulgaris: a randomized controlled trial	9
Role of ultra-high-frequency ultrasound in the diagnosis and management of basal cell carcinoma: pilot study based on 117 cases	9
Patient experiences with hidradenitis suppurativa: the Hidradenitis Patient Experience survey	9
The impact of COVID‐19 on dermatology outpatient services in England in 2020	9
Use of hydrochlorothiazide and risk of nonmelanoma skin cancer in Koreans: a retrospective cohort study using administrative healthcare data	9
Skin lightening: causes and complications	9
Effects of the COVID‐19 pandemic on head lice and scabies infestation dynamics: a population‐based study in France	9
Topical steroid withdrawal: an emerging clinical problem	9
Slack as a virtual undergraduate dermatology community: a pilot study	8
Lymphomatoid papulosis types D and E: a multicentre series of the French Cutaneous Lymphomas Study Group	8
Effect of gender-affirming hormone therapy on hair growth: a systematic review of the literature	8
Erythema annulare centrifugum induced by COVID‐19 vaccination	8
Favipiravir‐induced cutaneous adverse reactions in patients infected with COVID‐19	8
Menopause, skin and common dermatoses. Part 2: skin disorders	8
News on infantile haemangioma. Part 1: clinical course and pathomechanism	8
Ixekizumab‐induced paradoxical pustular reaction successfully treated with guselkumab	8
Rapid and sustained response to spesolimab in five Chinese patients with generalized pustular psoriasis	8
Lasting response after discontinuation of cemiplimab in a patient with locally advanced basal cell carcinoma	8
A pilot study of intralesional methotrexate injections versus triamcinolone acetonide in patients affected by nail matrix psoriasis	8
UK psychodermatology services in 2019: service provision has improved but is still very poor nationally	8
A review of the evidence for Mohs micrographic surgery. Part 2: basal cell carcinoma	8
Chronic venous disease. Part 1: pathophysiology and clinical features	8
Topical steroid withdrawal through the lens of social media	8
Male genital lichen sclerosus, microincontinence and occlusion: mapping the disease across the prepuce	8
Panton–Valentine leucocidin-producing Staphylococcus aureus: a clinical review	8
Co‐occurrence of Aicardi–Goutières syndrome type 6 and dyschromatosis symmetrica hereditaria due to compound heterozygous pathogenic variants in ADAR1 : a case series fr	8
Misdiagnosed scabies correctly diagnosed by dermoscopy using ultraviolet light mode	8
Anakinra for recalcitrant pyoderma gangrenosum	8
Clinical phenotypes and therapeutic responses in cutaneous‐predominant sarcoidosis: 6‐year experience in a tertiary referral service	8
Monkeypox: key pointers for dermatologists	8
Combination dermoscopy highlights fungal invasion of vellus hair in tinea vellus	8
Unintentional consequences of artificial intelligence in dermatology for patients with skin of colour	8
Every cloud has a silver lining: the environmental benefit of teledermatology during the COVID‐19 pandemic	8
Topical timolol in dermatology: infantile haemangiomas and beyond	8
Effect of the most common wound antiseptics on human skin fibroblasts	8

Serum tryptase levels in patients with psoriasis: a pilot study for a possible useful biomarker	8
The human microbiome in immunobullous disorders and lichen planus	8
Delayed localized hypersensitivity reactions to COVID‐19 mRNA vaccines: a 6‐month retrospective study	8
Ocular and auditory abnormalities in patients with vitiligo: a case–control study	8
ChatGPT versus clinician: challenging the diagnostic capabilities of artificial intelligence in dermatology	8
Pilot study of fractional microneedling radiofrequency for hidradenitis suppurativa assessed by clinical response and histology	7
	7
Inpatient teledermatology improves diagnostic accuracy and management of erythroderma in hospitalized patients	7
Laser therapy is a safe and effective treatment for unwanted hair in adults undergoing male to female sex reassignment	7
A qualitative review of misinformation and conspiracy theories in skin cancer	7
A review of Mohs micrographic surgery for skin cancer. Part 1: Melanoma and rare skin cancers	7
Retinoid-induced skeletal hyperostosis in disorders of keratinization	7
Association of prurigo nodularis and infectious disease hospitalizations: a national cross‐sectional study	7
The impact of COVID-19 pandemic on nonmelanoma skin cancers: report of a Southern Italy referral centre	7
Genes and phenotypes in vascular malformations	7
The chameleon rash: a review of the polyphenotypic dermatoses of dermatomyositis	7
Treatment of dissecting cellulitis of the scalp with tumour necrosis factor inhibitors: a retrospective multicentre study	7
Evaluation of efficacy and safety of oral voriconazole in the management of recalcitrant and recurrent dermatophytosis	7
Integrating neuronal involvement into the immune and genetic paradigm of vitiligo	7
Method of Assessing Skin Cancerization and KeratosesTM (MASCK™): development and photographic validation in multiple anatomical sites of a novel assessment tool intended for clinical evaluation of pat	7
Mechanisms of dermatological toxicities to immune checkpoint inhibitor cancer therapies	7
Limited utility of plasma elafin as a biomarker for skin graft‐versus‐host disease following allogeneic stem cell transplantation	7
Does topical minoxidil at concentrations higher than 5% provide additional clinical benefit?	7
Isotretinoin on TikTok™: misinformation getting under our skin	7
Comorbid mental health issues in patients with pemphigus vulgaris and pemphigus foliaceus	7
Bayesian network meta-analysis of head-to-head trials for complete resolution of nail psoriasis	7
The status and outcomes of registered clinical trials for Janus kinase inhibitors in alopecia areata: are unpublished trials being overlooked?	7
Validation of the RECap of AtoPic eczema measure of eczema control for use in dermatology clinics	7
Fast‐tracking teledermatology into dermatology trainee timetables, an overdue necessity in the COVID era and beyond	7
A paradigm shift in trainee confidence in teledermatology and virtual working during the COVID‐19 pandemic: results of a follow‐up UK‐wide survey	7
Comment on ‘Vitiligo in a COVID‐19‐vaccinated patient with ulcerative colitis: coincidence?’: Type I interferons as possible link between COVID‐19 vaccine and vitiligo	7
TikTok™, teens and isotretinoin: recommendations for identifying trending acne‐related content on the world’s most popular social media platform	7
Extracellular vesicles: a comprehensive review of their roles as biomarkers and potential therapeutics in psoriasis and psoriatic arthritis	7
Successful use of baricitinib in the treatment of refractory rheumatoid arthritis‐associated Sweet syndrome	7
Morphoea following COVID-19 vaccination	7
Vogt–Koyanagi–Harada‐like syndrome in the setting of combined anti‐PD1/anti‐CTLA4 therapy	7
Aquagenic wrinkling of the palms: review of the literature	7
Identification of clinically useful predictive genetic variants in pachyonychia congenita	7
Menopause, skin and common dermatoses. Part 1: hair disorders	7
Clinical and histopathological features of adult patients with dermatomyositis and melanoma differentiation associated‐5 autoantibody seropositivity status, as determined by commercially available tes	7
Severe and therapeutic challenging oral erosive lichen planus treated with oral roflumilast	7
Immune response to SARS-CoV-2 mRNA vaccine in patients with psoriasis treated with biologics	7
Off‐label use of dupilumab for the treatment of moderate to severe atopic dermatitis in children aged below 6 years of age: a case series	7
Socioeconomic status and skin cancer incidence: a population‐based, cohort study in the province of Ferrara, northern Italy	7
Acute spondyloarthritis developing during successful treatment with dupilumab for severe atopic dermatitis	6
‘Mask tinea’: tinea faciei possibly potentiated by prolonged mask usage during the COVID‐19 pandemic	6
Super‐high magnification dermoscopy can aid the differential diagnosis between melanoma and atypical naevi	6
On‐pack recycling label in cosmeceutical products in dermatology	6
Acquired perforating dermatoses show increased levels of cutaneous advanced glycation end‐products	6
Adherence to treatment with prescribed topical corticosteroid therapy and potential barriers to adherence among women with vulvar lichen sclerosus: a prospective cross‐sectional study	6
Longitudinal course and phenotypes of health‐related quality of life in adults with atopic dermatitis	6
The British Association of Dermatologists’ Undergraduate Curriculum Update 2021	6
Risankizumab‐induced paradoxical pustular psoriasis	6
Prevalence of vitamin D analogue toxicity in dogs	6
ChatGPT and dermatology: friends or foes?	6
Malignant acanthosis nigricans and diseases with extensive oral papillary hyperplasia	6
BRAF V600K vs. BRAF V600E: a comparison of clinical and dermoscopic characteristics and response to immunotherapies and targeted therapies	6
Narrowband ultraviolet B phototherapy is associated with a reduction in topical corticosteroid and clinical improvement in atopic dermatitis: a historical inception cohort study	6
The incidence of psoriasis in Chile: an analysis of the National Waiting List Repository	6
Predictors of time to definitive surgery and survival in Merkel cell carcinoma: analysis of the US National Cancer Database	6
Intramatricial injection of anti‐interleukin‐17A antibody for six patients with nail psoriasis	6
	6
Terbinafine-resistant Trichophyton indotineae causing extensive dermatophytosis in a returning traveller, London, UK	6
The novel AKT inhibitor afuresertib suppresses human Merkel cell carcinoma MKL‐1 cell growth	6
Elderly-onset generalized pustular psoriasis: a case series	6
Prevalence and incidence of vitiligo and associated comorbidities: a nationwide population-based study in Korea	6
Online crowdfunding for medical expenses related to hidradenitis suppurativa	6
Monkeypox: is topical cidofovir a good idea?	6
Acne and rosacea in skin of colour	6
Intradermal testing for autoimmune progesterone dermatitis: should we be basing the diagnosis on it?	6
Exploring the implications of the first COVID‐19 lockdown on patients with melanoma: a national survey	6
Severe atopic dermatitis and concurrent severe hidradenitis suppurativa successfully treated with dupilumab	6
Antiandrogen therapy in hidradenitis suppurativa: finasteride for females	6
Toxic epidermal necrolysis‐like lupus	6
A qualitative analysis of online misinformation and conspiracy theories in psoriasis	6
Atypical Spitz tumours: an epidemiological, clinical and dermoscopic multicentre study with 16 years of follow-up	6
Dupilumab unmasking cutaneous T‐cell lymphoma: report of a fatal case	6
Readability assessment of the British Association of Dermatologists’ patient information leaflets	6
Comparison of the efficacy and cost-effectiveness of an immunologically targeted low-dose rituximab protocol with the conventional rheumatoid arthritis protocol in severe pemphigus	6
NOD2 signalling in hidradenitis suppurativa	6
Emerging role of topical Janus kinase inhibitors in dermatological disorders: a review	6
Cepharanthine induces the proliferation of human dermal papilla cells and stimulates vascular endothelial growth factor expression through increased intracellular calcium mobilization and hypoxia‐indu	6
Evolving utility of apremilast in dermatological disorders for off-label indications	5
Influence of COVID‐19 confinement on the size of malignant skin tumours surgically removed at a Spanish hospital	5
Generalized granuloma annulare successfully treated with apremilast: report of two cases and literature review	5
Home viewing of educational video improves patient understanding of Mohs micrographic surgery	5
Beclin1 in psoriasis: an immunohistochemical study	5
Risankizumab for pityriasis rubra pilaris	5
Prevention of conjunctivitis in patients with atopic dermatitis undergoing treatment with dupilumab: an Italian single‐centre experience	5
Systemic minoxidil as maintenance treatment in alopecia areata: a retrospective case series of 24 patients	5
Spotting fake news: a qualitative review of misinformation and conspiracy theories in acne vulgaris	5
Comparison of cost changes due to the COVID‐19 pandemic for Dermatology residency applications in the USA	5
Immune profiling of lupus miliaris disseminatus faciei and successful management with anti‐tumour necrosis factor therapy	5
Successful treatment of severe recalcitrant vernal keratoconjunctivitis and atopic dermatitis associated with elevated IgE levels with omalizumab	5
Mood symptoms, neurodevelopmental traits, and their contributory factors in X-linked ichthyosis, ichthyosis vulgaris and psoriasis	5